分级为3级的重要性:呼吁对原发性非肌层浸润性膀胱癌采用三级混合分级系统
该研究基于三个独立队列共9712例原发性Ta-T1膀胱肿瘤,评估将WHO2004/2016高级别(HG)再分为HG/2级(G2)与HG/3级(G3)的混合三级分级系统的预后区分能力。多变量分析显示HG/G3进展时间显著短于HG/G2,混合分级模型的区分度优于WHO2004/2016,支持在Ta/T1膀胱癌中采用混合分级系统。
要点
- 三个队列多变量分析中HG/G3进展风险均显著高于HG/G2(HR分别为1.92、2.51、1.69)。
- 5年进展风险HG/G3为18%、20%、18%,HG/G2为7.3%、7.5%、9.3%。
- 混合分级C-index为0.74、0.68、0.78,均优于WHO2004/2016的0.69、0.62、0.75(均p<0.001)。
核心结论
- 将HG类别细分为HG/G2与HG/G3可分层进展时间,支持对Ta/T1膀胱癌采用混合分级系统的推荐。
研究设计与样本
- 分析了三个独立队列共9712例原发性(首次诊断)Ta-T1膀胱肿瘤。
- 采用累积发生率函数与Cox回归模型分析进展时间,并以Harrell C-index评估区分度。
主要发现
- 多变量分析中HG/G3进展时间显著短于HG/G2:队列1 HR=1.92,队列2 HR=2.51,队列3 HR=1.69。
- 5年进展风险HG/G3分别为18%、20%、18%,HG/G2分别为7.3%、7.5%、9.3%。
- 采用混合分级的Cox模型优于WHO2004/2016模型(所有队列p<0.001)。
- C-index:WHO2004/2016为0.69、0.62、0.75,混合分级为0.74、0.68、0.78。
关键数值与推荐
- 原文报告多变量分析中HG/G3相对HG/G2的进展风险HR=1.92(队列1)、HR=2.51(队列2)、HR=1.69(队列3)。
- 原文报告5年进展风险HG/G3为18%、20%、18%,HG/G2为7.3%、7.5%、9.3%。
- 原文报告混合分级C-index为0.74、0.68、0.78,WHO2004/2016为0.69、0.62、0.75。
临床怎么用
- 作者认为将HG类别细分为HG/G2与HG/G3可分层进展时间,并支持对Ta/T1膀胱癌采用混合分级系统的推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Grade is an important determinant of progression in non-muscle-invasive bladder cancer. Although the World Health Organization (WHO) 2004/2016 grading system is recommended, other systems such as WHO1973 and WHO1999 are still widely used. Recently, a hybrid (three-tier) system was proposed, separating WHO2004/2016 high grade (HG) into HG/grade 2 (G2) and HG/G3 while maintaining low grade. We assessed the prognostic performance of HG/G3 and HG/G2. Three independent cohorts with 9712 primary (first diagnosis) Ta-T1 bladder tumors were analyzed. Time to progression was analyzed with cumulative incidence functions and Cox regression models. Harrell's C-index was used to assess discrimination. Time to progression was significantly shorter for HG/G3 than for HG/G2 in multivariable analyses (cohort 1: hazard ratio [HR] = 1.92; cohort 2: HR = 2.51, and cohort 3: HR = 1.69). Corresponding progression risks at 5 yr were 18%, 20%, and 18% for HG/G3 versus 7.3%, 7.5%, and 9.3% for HG/G2, respectively. Cox models using hybrid grade performed better than models with WHO2004/2016 (all cohorts; p < 0.001). For the three cohorts, C-indices for WHO2004/2016 were 0.69, 0.62, and 0.75, while, for hybrid grade, C-indices were 0.74, 0.68, and 0.78, respectively. Subdividing the HG category into HG/G2 and HG/G3 stratifies time to progression and supports the recommendation to adopt the hybrid grading system for Ta/T1 bladder cancers.
引用
- Beijert IJ, Hagberg O, Gårdmark T, et al. The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer. Eur Urol. 2024. PMID: 39209674. doi:10.1016/j.eururo.2024.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。